Table 1. Demographic characteristics of the subjects.
State | No | Gender | Age (yr) | HCV# | HCV RNA? | ALT* | Co-existing disease |
self-limited infection | 1 | F | 45 | 15.15 | negative | 12 | no |
2 | M | 59 | 8.71 | negative | 15 | no | |
3 | M | 60 | 5.83 | negative | 18 | fatty liver | |
4 | M | 58 | 6.46 | negative | 12 | fatty liver | |
5 | F | 43 | 6.17 | negative | 13 | no | |
chronic infection | 6 | F | 45 | 14.76 | 4.91E+06 | 18 | no |
7 | M | 50 | 15.19 | 4.88E+06 | 20 | no | |
8 | M | 39 | 12.75 | 1.31E+07 | 44 | alcohol | |
9 | F | 41 | 12.45 | 9.74E+05 | 26 | no | |
10 | M | 47 | 14.65 | 2.02E+04 | 134 | no | |
11 | M | 50 | 11.29 | 1.26E+07 | 31 | fatty liver |
Note: #HCV Abs detected by ELISA (S/Co, Abbott).
Virus loads were quantified through quantitative real-time Taqman PCR (IU/mL, Roche).
ALT (IU/mL);
“no” means no combined diseases.